Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
Background: Cancer is the second leading cause of death globally accounting for more than half of deaths in Low- and Middle-Income Countries (LMICs). Cancer treatment is expensive and the high prices of cancer medicines have a huge impact on access in LMICs. Scarcity of pricing or affordability data...
Saved in:
Main Authors: | Phyllis Ocran Mattila (Author), Rabbiya Ahmad (Author), Syed Shahzad Hasan (Author), Zaheer- (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
by: Zaheer-, et al.
Published: (2019) -
Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
by: Phyllis Ocran Mattila, et al.
Published: (2021) -
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico
by: Daniela Moye-Holz, et al.
Published: (2020) -
Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings.
by: Trishul Siddharthan, et al.
Published: (2022) -
Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings
by: Trishul Siddharthan, et al.
Published: (2022)